XML 59 R43.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Parent-Only Financial Statements (Tables) - Parent [Member] | 12 Months Ended
--- | ---
Dec. 31, 2023
Parent-Only Financial Statements (Tables) [Line Items] |
Schedule of Condensed Balance Sheets |
|  | As of December 31,
|  | 2022 |  | 2023
|  | RMB |  | RMB |  | US$
ASSETS/(LIABILITIES) |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | 25,769 |  |  | 1,205,993 |  |  | 170,273 |
Prepayments |  | — |  |  | 13,776 |  |  | 1,945 |
Due from intercompany |  | 380,321,338 |  |  | 456,041,568 |  |  | 64,388,096 |
Investment in subsidiaries |  | (215,932,707 | ) |  | (471,994,335 | ) |  | (66,640,453 | )
TOTAL ASSETS (LIABILITIES) |  | 164,414,400 |  |  | (14,732,998 | ) |  | (2,080,139 | )
SHAREHOLDERS’ EQUITY (DEFICIT) |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit): |  |  |  |  |  |  |  |  |
Class A ordinary shares ($0.0002 par value; 121,410,923 shares authorized; 27,159,258 and 41,927,302 shares issued as of December 31, 2022 and 2023, respectively; 27,159,258 and 37,242,359 shares outstanding as of December 31, 2022 and 2023, respectively)* |  | 35,425 |  |  | 50,106 |  |  | 7,074 |
Class B ordinary shares ($0.0002 par value; 28,589,078 shares authorized; 28,589,078 shares issued and outstanding as of December 31, 2022 and 2023)* |  | 36,894 |  |  | 36,894 |  |  | 5,209 |
Additional paid-in capital |  | 354,803,564 |  |  | 428,310,028 |  |  | 60,472,705 |
Accumulated deficit |  | (199,207,921 | ) |  | (452,031,693 | ) |  | (63,821,945 | )
Statutory reserves |  | 6,647,109 |  |  | 6,647,109 |  |  | 938,499 |
Accumulated other comprehensive income |  | 2,099,329 |  |  | 2,254,558 |  |  | 318,319 |
TOTAL NANO LABS LTD SHAREHOLDERS’ EQUITY (DEFICIT) |  | 164,414,400 |  |  | (14,732,998 | ) |  | (2,080,139 | )
* After giving effect of the reverse stock split, see Note 1.
Schedule of Condensed Statements of Operations and Comprehensive Income (Loss) |
|  | For the years ended December 31,
|  | 2021 |  | 2022 |  | 2023
|  | RMB |  | RMB |  | RMB |  | US$
Net revenues |  | — |  |  | — |  |  | — |  |  | — |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Selling and marketing expenses |  | 980 |  |  | — |  |  | — |  |  | — |
General and administrative expenses |  | 306,775 |  |  | 5,822,906 |  |  | 471,664 |  |  | 66,594 |
Total operating expenses |  | 307,755 |  |  | 5,822,906 |  |  | 471,664 |  |  | 66,594 |
Loss from operations |  | (307,755 | ) |  | (5,822,906 | ) |  | (471,664 | ) |  | (66,594 | )
Finance income |  | — |  |  | 66,144 |  |  | 110,971 |  |  | 15,668 |
Investment income |  | — |  |  | 53,809 |  |  | — |  |  | — |
Income (loss) from investment in subsidiaries |  | (174,636,729 | ) |  | 36,821,839 |  |  | (252,463,079 | ) |  | (35,645,033 | )
Net income (loss) attributable to Nano Labs Ltd |  | (174,944,484 | ) |  | 31,118,886 |  |  | (252,823,772 | ) |  | (35,695,959 | )
Comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | (174,944,484 | ) |  | 31,118,886 |  |  | (252,823,772 | ) |  | (35,695,959 | )
Other comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  | (2,467,327 | ) |  | 4,566,656 |  |  | 155,229 |  |  | 21,917 |
Total comprehensive income (loss) attributable to Nano Labs Ltd |  | (177,411,811 | ) |  | 35,685,542 |  |  | (252,668,543 | ) |  | (35,674,042 | )
Schedule of Condensed Statements of Cash Flows |
|  | For the years ended December 31,
|  | 2021 |  | 2022 |  | 2023
|  | RMB |  | RMB |  | RMB |  | US$
Net cash provided by (used in) operating activities |  | (535,017 | ) |  | 3,911,561 |  |  | 344,012 |  |  | 48,571 |
Net cash used in investing activities |  | (201,554,446 | ) |  | (155,900,936 | ) |  | (68,918,960 | ) |  | (9,730,605 | )
Net cash provided by financing activities |  | 201,251,124 |  |  | 144,043,186 |  |  | 72,802,734 |  |  | 10,278,952 |
Effect of exchange rate changes on cash and cash equivalents |  | 926,910 |  |  | 7,883,387 |  |  | (3,047,562 | ) |  | (430,284 | )
Net increase (decrease) in cash and cash equivalents |  | 88,571 |  |  | (62,802 | ) |  | 1,180,224 |  |  | 166,634 |
Cash and cash equivalents at beginning of the year |  | — |  |  | 88,571 |  |  | 25,769 |  |  | 3,639 |
Cash and cash equivalents at end of the year |  | 88,571 |  |  | 25,769 |  |  | 1,205,993 |  |  | 170,273 |

X
- References No definition available. + Details
Name: | ck0001872302_ParentOnlyFinancialStatementsTablesLineItems
Namespace Prefix: | ck0001872302_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |